--2025/Q1-- / 13.590B--
--2024/Q4-- / 14.126B--
Nov 12, 20242024/Q313.565B / 13.102B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--
US Stock MarketDetailed Quotes
AZN AstraZeneca
- 63.880
- +0.490+0.77%
Trading Nov 19 13:11 ET
198.07BMarket Cap30.79P/E (TTM)
64.130High63.305Low3.23MVolume63.650Open63.390Pre Close206.06MTurnover0.11%Turnover Ratio33.53P/E (Static)3.10BShares87.67552wk High4.86P/B197.37BFloat Cap59.19052wk Low1.49Dividend TTM3.09BShs Float87.675Historical High2.32%Div YieldTTM1.30%Amplitude5.373Historical Low63.724Avg Price1Lot Size
AstraZeneca Key Stats
AstraZeneca Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 13.10B | 13.57B | +462.53M |
| Beat Est. | +14.01% | +18.04% | +3.53% |
| EPS | 0.77 | 0.46 | -0.32 |
| Miss Est. | +73.46% | +3.41% | -41.05% |
Analyst Rating
Nov 19, 2024
AstraZeneca Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
AstraZeneca Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
